Search Results - "Fuentes, Javier David Benitez"
-
1
The Missed Opportunity: HIV, Hepatitis C Virus (HCV), and Hepatitis B Virus (HBV) Positive Patients in Neoadjuvant and Perioperative Immunotherapy Clinical Trials for Lung Cancer
Published in Curēus (Palo Alto, CA) (29-12-2023)“…This editorial addresses a critical oversight in recent clinical trials on neoadjuvant or perioperative immunotherapy for lung cancer, the exclusion of…”
Get full text
Journal Article -
2
Achieving complete metabolic response in stage IV lung adenocarcinoma with chemotherapy, nivolumab, ipilimumab, and salvage SBRT: A case report
Published in Respirology case reports (01-04-2024)“…Oncogene-negative, PDL1-negative metastatic non-small cell lung cancer (NSCLC) presents significant treatment challenges due to its complexity and resistance…”
Get full text
Journal Article -
3
Efficacy of carboplatin-etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis
Published in Therapeutic advances in medical oncology (01-01-2024)“…Second-line treatment for small-cell lung cancer (SCLC) is primarily guided by the time elapsed since the last platinum dose. Rechallenge with carboplatin and…”
Get full text
Journal Article -
4
Perforation of the Nasal Septum in a Colorectal Cancer Patient Treated With Aflibercept: A Case Report
Published in Curēus (Palo Alto, CA) (12-07-2022)“…Aflibercept is an antiangiogenic agent used in patients with metastatic colorectal cancer who have progressed to a first-line oxaliplatin-based regimen. The…”
Get full text
Journal Article -
5
Case Report: Bocavirus Infection Radiologically Resembling a Congestive Heart Failure in a Patient with Metastatic Castration-Resistant Prostate Cancer [version 2; peer review: 2 approved]
Published in F1000 research (2022)“…Background: Human bocavirus (HBoV) is a viral pathogen from the genus Bocaparvovirus (family Parvoviridae, subfamily Parvovirinae) discovered in 2005. Most of…”
Get full text
Journal Article -
6
Prognostic value of human leukocyte antigen G expression in solid tumors: a systematic review and meta-analysis
Published in Frontiers in immunology (18-05-2023)“…Identification of modulators of the immune response with inhibitory properties that could be susceptible for therapeutic intervention is a key goal in cancer…”
Get full text
Journal Article -
7
Evidence of exhausted lymphocytes after the third anti-SARS-CoV-2 vaccine dose in cancer patients
Published in Frontiers in oncology (20-12-2022)“…Evidence is scant regarding the long-term humoral and cellular responses Q7 triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA…”
Get full text
Journal Article -
8
Clinical Behavior, Mutational Profile and T-Cell Repertoire of High-Grade Neuroendocrine Tumors of the Head and Neck
Published in Cancers (24-04-2023)“…Neuroendocrine carcinomas (NECs) of the head and neck (HN) account for <1% of HN cancers (HNCs), with a 5-year overall survival (OS) <20%. This is a…”
Get full text
Journal Article -
9
Clinical Experience with Abemaciclib in Patients Previously Treated with Another CDK 4/6 Inhibitor in a Tertiary Hospital: A Case Series Study
Published in Cancers (01-09-2023)“…The three approved cyclin-dependent kinase 4/6 (CDK4/6) inhibitors, including abemaciclib, have shown differences in their preclinical, pharmacological, and…”
Get full text
Journal Article -
10
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain [version 2; peer review: 2 approved]
Published in F1000 research (2022)“…Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines efficacy and safety have been tested in phase 3 studies in which cancer…”
Get full text
Journal Article -
11
Adverse drug reactions to the three doses of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) mRNA-1273 vaccine in a cohort of cancer patients under active treatment of a tertiary hospital in Madrid, Spain [version 1; peer review: 1 approved with reservations]
Published in F1000 research (2022)“…Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines efficacy and safety have been tested in phase 3 studies in which cancer…”
Get full text
Journal Article -
12
Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors
Published in Biomedicines (28-03-2023)“…Patients with antibody deficiency disorders, such as primary immunodeficiency (PID) or secondary immunodeficiency (SID) to B-cell lymphoproliferative disorder…”
Get full text
Journal Article -
13
Clarification Regarding Breast Cancer Stage in France-Reply
Published in JAMA oncology (01-06-2024)Get more information
Journal Article -
14
Prognostic value of human leukocyte antigen G (HLA-G) expression in solid tumors: A systematic review and meta-analysis
Published in Journal of clinical oncology (01-06-2023)“…e14639 Background: Identification of modulators of the immune response with inhibitory properties that could be susceptible for therapeutic intervention is a…”
Get full text
Journal Article -
15
High-grade neuroendocrine head and neck cancer: Case series and review of the literature
Published in Current problems in cancer (01-08-2024)“…High-grade neuroendocrine cancers (NEC) of the head and neck (HN) are rare and aggressive, accounting for ≤1 % of all HN cancers, with a 5-year overall…”
Get full text
Journal Article -
16
Adverse drug reactions of the SARS-CoV-2 mRNA-1273 vaccine in a cohort of cancer patients of a tertiary hospital in Madrid, Spain
Published in Journal of clinical oncology (01-06-2022)“…e24072 Background: SARS-CoV-2 vaccines efficacy and safety have been tested in phase 3 studies which did not include cancer patients. Information is scarce…”
Get full text
Journal Article -
17
Efficacy analysis of CDK4/6 inhibitors (CDKi) + endocrine therapy (ET) treatment in hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer (aBC): Biomarker analysis including chemoendocrine score (CES) by CDKi type in SOLTI-1801_CDK-PREDICT study
Published in Journal of clinical oncology (01-06-2023)“…1065 Background: CDKi + ET improved progression-free survival (PFS) and ribociclib also overall survival (OS) in HR+/HER2- aBC first-line setting. Intrinsic…”
Get full text
Journal Article -
18
Global Stage Distribution of Breast Cancer at Diagnosis: A Systematic Review and Meta-Analysis
Published in JAMA oncology (01-01-2024)“…Stage at diagnosis is a key prognostic factor for cancer survival. To assess the global distribution of breast cancer stage by country, age group, calendar…”
Get more information
Journal Article -
19
Case Report: Bocavirus Infection Radiologically Resembling a Congestive Heart Failure in a Patient with Metastatic Castration-Resistant Prostate Cancer Case-Report [version 1; peer review: 1 approved, 1 approved with reservations]
Published in F1000 research (2022)“…Background: Human bocavirus (HBoV) is a viral pathogen from the genus Bocaparvovirus (family Parvoviridae, subfamily Parvovirinae) discovered in 2005. Most of…”
Get full text
Journal Article -
20
Achieving complete metabolic response in stage IV lung adenocarcinoma with chemotherapy, nivolumab, ipilimumab, and salvage SBRT: A case report
Published in Respirology case reports (01-04-2024)“…Oncogene-negative, PDL1-negative metastatic non-small cell lung cancer (NSCLC) presents significant treatment challenges due to its complexity and resistance…”
Get full text
Report